Replies to post #2380 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

Baraclude Sales Ramp 2005-Present

[Updated with 1Q08 sales.]


2Q05 $5M (US launch Apr 05)
3Q05 $2M
4Q05 $5M
1Q06 $11M (China launch Feb 06)
====
First year on market: $23M


2Q06 $14M
3Q06 $22M (Japan, partial EU launches Jul 06)
4Q06 $36M
1Q07 $45M (added to AASLD guidelines Feb 07)
====
Second year on market: $117M


2Q07 $59M
3Q07 $72M
4Q07 $99M
1Q08 $108M
====
Third year on market: $348M

My prior sales forecast for Baraclude’s third year on the market had been $345M (#msg-26443005).


Can Tyzeka/Sebivo still have a sales ramp like Baraclude’s in spite of its slow as molasses start? I wish I knew.